Overview

ICTUS Study: International Citicoline Trial on Acute Stroke

Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Citicoline is a safe drug approved in some countries for the treatment of acute ischemic stroke. The drug has shown some evidence of efficacy in a pooled analysis, based on four clinical trials done in USA with oral citicoline.The purpose of the study is confirm the results obtained in the pooled analysis, that is, evidence of efficacy in the treatment of acute ischemic stroke
Phase:
Phase 3
Details
Lead Sponsor:
Ferrer Internacional S.A.
Treatments:
Choline
Cytidine Diphosphate Choline